Medicare 2027 Part D Premium: Millions of Medicare beneficiaries are about to feel the effects of a federal subsidy program disappearing, and the Medicare 2027 Part D Premium picture is starting to come into focus even before the government’s final numbers are out. The Centers for Medicare and Medicaid Services confirmed in late July 2026 that it will end the Part D Premium Stabilization Demonstration after this year, a program that has quietly kept standalone drug plan premiums lower since 2025. We’ll be updating this article monthly as CMS releases the complete 2027 landscape and as plan-specific premium letters begin reaching mailboxes, so check back here for the latest confirmed figures rather than relying on early projections.

For the roughly 25 million people enrolled in standalone Part D prescription drug plans, the timing matters because the full picture is not public yet. CMS has released the two technical numbers that set the stage for everyone’s 2027 premium, the national average monthly bid amount and the base beneficiary premium, but the actual dollar figure each person will pay depends on their specific plan, and those details are expected only in mid to late September 2026, right before Medicare’s annual open enrollment window opens on October 15. This guide walks through everything CMS has confirmed so far, what is ending and why, and what beneficiaries should watch for in the coming weeks.

What CMS Has Officially Announced for 2027?

On July 28, 2026, CMS released its annual technical bid information for the coming plan year, confirming two figures that anchor every Part D premium calculation. The 2027 national average monthly bid amount (NAMBA) was set at $296.05, an increase of roughly 24 percent from the 2026 figure of $239.27. The 2027 Part D base beneficiary premium was set at $41.33, up from $38.99 in 2026, a 6 percent increase that matches the statutory cap Congress placed on how quickly this baseline figure can rise through 2029 under the Inflation Reduction Act.

Neither of these two numbers is the actual premium any individual beneficiary will pay. The NAMBA is a technical, enrollment-weighted average of what insurers bid to provide the standard drug benefit, used mainly to calculate the federal subsidy paid to plan sponsors. The base beneficiary premium is a statutory starting point plugged into a formula that produces each plan’s specific premium, adjusted for that plan’s own bid, region, and benefit design. In plain terms, both figures signal that cost pressure is building across the Part D program, but they do not tell any single Medicare beneficiary what their own drug plan will actually cost next year.

Why the Part D Premium Stabilization Demonstration Is Ending

The bigger story behind this year’s numbers is not the bid figures themselves but a policy decision layered on top of them. Alongside the July 28 bid release, CMS announced it will discontinue the Part D Premium Stabilization Demonstration at the end of contract year 2026, a voluntary program first introduced in 2025 to help standalone drug plans adjust smoothly to the Inflation Reduction Act’s redesigned Part D benefit.

The demonstration worked by giving participating plan sponsors a flat premium reduction, roughly $10 per member per month in its second year, along with a cap limiting how much any single plan’s premium could increase year over year. Nearly every standalone Part D enrollee in the country has been in a plan that opted into this program for both 2025 and 2026, which is a major reason the average stand-alone Part D premium actually fell, from $38.31 in 2025 to $34.50 in 2026, even as underlying drug costs kept climbing.

CMS Administrator Mehmet Oz explained the decision to end the program by pointing to how plan sponsors have adapted. According to the agency, insurers now have two full years of real-world pricing experience under the redesigned benefit structure, including the new $2,100 out-of-pocket cap that took effect in 2026, and no longer need the additional federal support to price their plans accurately. CMS has framed this as a return to normal market conditions rather than a cut to the Part D benefit itself.

Medicare 2027 Part D Premium Key Dates

Timeline: How This Announcement Unfolded

Amazon Prime Settlement Refund: Who Qualifies for Up to $200 Now?

FEHB 2026 Open Season: Which Plans Left and What It Means for Your Premium?

CPP OAS GIS Payment Amounts: September 25 Deposit, October Increase and Free Calculator

How Much Could Your Premium Actually Go Up?

CMS has publicly estimated that most Medicare beneficiaries will see their Part D premium rise by less than $10 a month for 2027, and the agency has said some beneficiaries could even see their premium fall, depending on which plan they choose and how competitive their local market remains. That estimate applies broadly across the program, but it masks a real difference between two very different groups of enrollees.

Beneficiaries in standalone Prescription Drug Plans, the roughly 25 million people who buy drug coverage separately from their Medicare Advantage or Original Medicare coverage, are the group most directly affected by the subsidy’s end, since the flat $10 reduction and premium increase cap built into the demonstration disappear entirely starting with the 2027 plan year. Independent analysts covering the Part D market have pointed to the 24 percent jump in the national average bid amount as evidence that underlying cost pressure in this market segment remains significant, even though CMS’s own guidance suggests the typical dollar increase will be modest for most people.

Beneficiaries enrolled in Medicare Advantage plans with drug coverage (MA-PD) are generally expected to see smaller and more varied changes, since these plans blend drug costs into a broader benefit package that is not tied to the ending demonstration in the same direct way. As with any Medicare Advantage plan, however, premiums, formularies, and pharmacy networks are set at the individual plan level and can vary significantly by county.

What Is Not Changing in 2027?

Amid understandable concern about rising costs, it is worth being clear about what the end of the Premium Stabilization Demonstration does not affect. Medicare Part D is not ending, and the underlying prescription drug benefit continues as a required part of the Medicare program in 2027. The Extra Help program, also called the Low-Income Subsidy, continues unchanged, and eligible beneficiaries remain protected from most premium increases regardless of what happens in the broader market. The Inflation Reduction Act’s signature consumer protection, the annual out-of-pocket spending cap, also remains fully in place and is actually rising slightly, from $2,100 in 2026 to a confirmed $2,400 in 2027, meaning no Medicare beneficiary will pay more than that amount out of pocket for covered prescription drugs in a calendar year regardless of what their premium looks like.

The Medicare Prescription Payment Plan, which lets beneficiaries spread their out-of-pocket drug costs into predictable monthly installments across the year rather than paying large amounts at the pharmacy counter, also continues to be available to every Part D enrollee in 2027, at every plan’s own choosing to participate.

How to Apply, Compare Plans and Check Your Status?

Medicare beneficiaries do not need to reapply for Part D coverage each year, but reviewing and potentially switching plans during open enrollment is strongly recommended given the scale of change happening in the standalone PDP market this year.

1. Watch your mailbox for your plan’s Annual Notice of Change (ANOC) letter, which must arrive by September 30, 2026, and will show your specific 2027 premium, deductible, and any changes to covered drugs.
2. Once CMS publishes the full landscape in mid to late September, use the Medicare Plan Finder tool on Medicare.gov to compare your current plan’s 2027 pricing against other available options in your area.
3. If you decide to switch plans, complete your change during the Medicare Open Enrollment Period, which runs from October 15 through December 7, 2026, for coverage beginning January 1, 2027.
4. If you believe you qualify for Extra Help based on limited income and resources, apply through the Social Security Administration, since this can substantially reduce or eliminate your Part D premium regardless of the broader market changes.
5. Confirm your enrollment and coverage start date through your MyMedicare.gov account once your new selection is processed.

Processing Time for Plan Changes

Once a beneficiary selects a new Part D plan during open enrollment, the change generally takes effect automatically on January 1 of the following year, without requiring a separate approval or waiting period, provided the switch is completed within the enrollment window. Special Enrollment Periods, available for qualifying life events such as moving out of a plan’s service area or losing other creditable drug coverage, are typically processed within the same enrollment cycle, with new coverage usually beginning the month after the request is submitted, depending on the specific circumstance.

Payment Schedule for Part D Premiums

Part D premiums are generally billed monthly, either directly by the plan, deducted from a beneficiary’s Social Security payment, or, for higher earners, adjusted upward through the Income-Related Monthly Adjustment Amount (IRMAA), which is billed separately by Medicare based on income reported on a beneficiary’s tax return from two years prior. Beneficiaries who anticipate difficulty managing a lump-sum pharmacy bill can also enroll in the Medicare Prescription Payment Plan, which converts variable out-of-pocket drug costs into a fixed monthly payment schedule spread across the calendar year rather than requiring payment at the point of sale.

IRS 2027 Tax Brackets: How Much Can You Earn Before Hitting the 37% Rate

32-Hour Workweek Bill: What the Thirty-Two Hour Workweek Act Means for Your Paycheck

Flat-Rate COLA: What the 2027 Social Security Proposal Really Means for Retirees

Official Resources and Where to Check Your Plan

Always confirm the exact premium, deductible, and formulary for your specific plan directly through Medicare.gov or your Annual Notice of Change letter, since figures published before the September landscape release are projections rather than final numbers.

How This Compares With Past Years

Context helps explain why this year’s announcement is drawing more attention than usual. The Part D Premium Stabilization Demonstration was originally introduced specifically because the Inflation Reduction Act’s 2025 benefit redesign, which eliminated the old coverage gap and introduced the annual out-of-pocket cap, created a real risk of premium volatility as insurers adjusted to entirely new cost-sharing rules. In its first year, the demonstration reduced premiums using a formula tied to each plan’s own bid; in its second year, CMS simplified it into a flat $10 reduction alongside a $50 cap on how much any single plan’s premium could rise year over year.

That structure worked as intended in the sense that average standalone Part D premiums actually declined between 2025 and 2026, even as the NAMBA and other underlying cost indicators kept climbing. Ending the program removes both the flat discount and the increase cap at the same time, which is why analysts are watching the 2027 landscape release so closely. A plan that might otherwise have raised its premium by $8 under the old cap could, in theory, raise it by considerably more once that ceiling disappears, though CMS’s public guidance suggests this will be the exception rather than the rule for most beneficiaries.

Impact on Different Groups of Beneficiaries

Not every Medicare beneficiary will experience this change the same way. Beneficiaries who have remained on a low-cost standalone PDP purely because it offered the lowest premium in their area may be the most exposed, since some of the very lowest-premium plans were also among the biggest beneficiaries of the now-ending subsidy. Beneficiaries with more complex medication needs, who typically choose plans based on formulary coverage rather than premium alone, may see less disruption if their preferred plan’s pricing was less dependent on the demonstration to begin with.

Dual-eligible beneficiaries who qualify for both Medicare and Medicaid, along with those receiving Extra Help, are the most insulated group, since federal rules cap what these beneficiaries pay toward Part D premiums regardless of how the broader market shifts. Beneficiaries approaching their first Medicare enrollment in 2027 will simply encounter the new pricing environment as the baseline, without the point of comparison that longtime enrollees have to previous, subsidy-supported years.

What to Watch for in the Coming Weeks

Two milestones will turn today’s projections into real numbers for individual beneficiaries. First, CMS’s mid to late September landscape release will publish plan-specific premiums, deductibles, and formularies for every Part D and Medicare Advantage plan nationwide, giving the first true picture of how the end of the stabilization demonstration is playing out at the plan level rather than as a national average. Second, every current Part D enrollee should receive an Annual Notice of Change letter from their existing plan by September 30, spelling out exactly how that specific plan’s premium and benefits are changing for 2027.

Industry analysts tracking the standalone PDP market note that the number of stand-alone plan offerings has already been shrinking, from thousands of options in prior years down to a few hundred nationally, a trend that predates this year’s subsidy decision but is expected to continue as sponsors consolidate their offerings under the redesigned benefit. Beneficiaries who have stuck with the same Part D plan for several years without comparing options are especially encouraged to review their Annual Notice of Change closely this year, since even plans that previously offered low premiums under the subsidy program could see meaningfully different pricing once that support disappears.

2027 Medicare Part D Premium Estimator

Conclusion

The Medicare 2027 Part D Premium story is still unfolding, with CMS having confirmed the technical building blocks, a $296.05 national average bid amount and a $41.33 base beneficiary premium, while the actual dollar figure most beneficiaries will pay remains unpublished until the agency’s landscape release in mid to late September 2026. What is clear already is that the temporary subsidy that helped hold standalone drug plan premiums down in 2025 and 2026 is ending, that CMS expects a modest average increase of under $10 a month for most people even as some standalone plans could rise more, and that core consumer protections, including the $2,400 out-of-pocket cap and Extra Help, remain firmly in place. Beneficiaries should watch for their Annual Notice of Change letter, compare plans once the full landscape is published, and use Medicare’s open enrollment window from October 15 to December 7 to make sure their coverage still fits their needs and budget for 2027.

Hungary Poland Immigrant Visa Resumption: What Changed and Who Is Affected?

DHS LPR Rule for Foreign Government Employees’ Children: Eligibility, Fees and How to Apply

HUD-VASH Housing Voucher New 2026 Eligibility Rules Explained

FAQs

US Russia Sanctions Bill 2026: 100% Tariff Threat to India Explained

Medicaid Work Requirements 2026: New Rule Rollout, State Start Dates and Who Is Exempt

ABLE Account Eligibility 2026: Who Qualifies Now, New Age Limit and Calculator